Avalyn Pharma Inc (AVLN)

Avalyn Pharma Inc Azioni (AVLN) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31
Durata del periodo	3 mesi	3 mesi
	12.11%31.29	27.91
Research and Development	8.04%24.73	22.89
Operating Income/Loss	12.11%-31.29	-27.91
Nonoperating Income/Loss	126.44%2.36	1.04
Income Tax Expense/Benefit	-	-
	7.69%-28.94	-26.87
Attributable To Parent	7.69%-28.94	-26.87
Available To Common Stockholders, Basic	7.69%-28.94	-26.87
Basic Average Shares	2,309%29.65	1.23
Diluted Average Shares	2,309%29.65	1.23
Basic Earnings Per Share	95.51%-0.98	-21.83
Diluted Earnings Per Share	95.51%-0.98	-21.83